Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma

Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma

Surgery followed by chemoradiation and adjuvant chemotherapy is standard of care for patients with a glioblastoma (GBM). Due to its limited benefit, an upfront method to predict dismal outcome would prevent unnecessary toxic treatment. We searched for a predictive blood derived biomarker in a cohort...

Full description

Bibliographic Details
Main Authors: van Linde, Myra E., van der Mijn, Johannes C., Pham, Thang V., Knol, Jaco C., Wedekind, Laurine E., Hovinga, Koos E., Aliaga, Esther Sanchez, Buter, Jan, Jimenez, Connie R., Reijneveld, Jaap C., Verheul, Henk M. W.
Format: Online
Language:English
Published: Springer US 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992035/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992035/

Similar Items